COCP - Cocrystal Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---78
Cost of Revenue4,6675,822101,67947,261
Gross Profit-4,667-5,822-101,679-47,183
Operating Expenses
Research Development----
Selling General and Administrative4,3523,3364,1406,765
Non Recurring----
Total Operating Expenses9,0199,158105,81954,026
Operating Income or Loss-9,019-9,158-105,819-53,948
Income from Continuing Operations
Total Other Income/Expenses Net-53,6111,6651,551-11,422
Earnings Before Interest and Taxes-9,019-9,158-105,819-53,948
Interest Expense-58-7-7-7
Income Before Tax-62,630-7,493-104,268-65,370
Income Tax Expense-13,582-6,880-29,394-15,248
Minority Interest----
Net Income From Continuing Ops-49,048-613-74,874-50,122
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-49,048-613-74,874-50,122
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-49,048-613-74,874-50,122